Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
Saved in:
Main Authors: | Borges,Ana Flávia, Molina,Juliana D'Andrea, Abreu,Marilda Aparecida Milanez Morgado de |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Medicina Tropical - SBMT
2021
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S0037-86822021000100824 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mucocutaneous leishmaniasis treated with liposomal amphotericin B
by: Lambertucci,José Roberto, et al.
Published: (2008) -
Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case
by: Gomes,Maria Antonia Ferreira, et al.
Published: (2018) -
Amphotericin B is usually underdosed in the treatment of experimental cutaneous leishmaniasis
by: Sifontes-Rodríguez,Sergio, et al.
Published: (2022) -
Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
by: Tuon,Felipe Francisco, et al.
Published: (2018) -
Comparison of Amphotericin B Lipid Complex (Abelcet) and Liposomal Amphotericin B (Ambisome) on Rat Kidney: a Morphological Evaluation
by: Mutluay,S. Deniz, et al.
Published: (2012)